Kolon Life Science Inc (102940) — Free Cash Flow Generation Index

Latest as of September 2025: -2.12x

Kolon Life Science Inc (102940) has a Free Cash Flow Generation Index of -2.12x as of September 2025. Free cash flow of ₩-5.47 Billion represents -2% of operating cash flow (₩2.58 Billion). Read 102940 current and long-term liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

-2.12x
Free Cash Flow / Operating CF

Free Cash Flow

₩-5.47 Billion
KRW

Operating Cash Flow

₩2.58 Billion
KRW

Capital Expenditures

₩8.05 Billion
KRW

Kolon Life Science Inc Free Cash Flow Generation Index (2011–2016)

Historical FCF Generation Index trend for Kolon Life Science Inc across 5 annual periods. Explore how much does Kolon Life Science Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Kolon Life Science Inc (2011–2016)

Year-by-year Free Cash Flow Generation Index for Kolon Life Science Inc. For the full company profile including market capitalisation, see Kolon Life Science Inc (102940) total market value.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2016 1.57x ₩44.25 Billion ₩28.11 Billion ₩16.14 Billion ▼ -9.1%
2015 1.73x ₩36.02 Billion ₩20.81 Billion ₩15.22 Billion ▼ -22.7%
2014 2.24x ₩27.10 Billion ₩12.10 Billion ₩15.01 Billion ▼ -37.9%
2012 3.61x ₩84.38 Billion ₩23.37 Billion ₩61.01 Billion ▲ +7.4%
2011 3.36x ₩39.17 Billion ₩11.65 Billion ₩27.52 Billion
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).